189 related articles for article (PubMed ID: 1359646)
1. Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector.
Chatterjee S; Johnson PR; Wong KK
Science; 1992 Nov; 258(5087):1485-8. PubMed ID: 1359646
[TBL] [Abstract][Full Text] [Related]
2. Molecular approaches to inhibit HIV-1 tat expression and functions.
Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
[No Abstract] [Full Text] [Related]
3. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.
Lo KM; Biasolo MA; Dehni G; Palú G; Haseltine WA
Virology; 1992 Sep; 190(1):176-83. PubMed ID: 1529527
[TBL] [Abstract][Full Text] [Related]
5. Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys.
Smith C; Lee SW; Wong E; Gallardo H; Page K; Gaspar O; Lebkowski J; Gilboa E
Antiviral Res; 1996 Oct; 32(2):99-115. PubMed ID: 8891169
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s).
Cohli H; Fan B; Joshi RL; Ramezani A; Li X; Joshi S
Antisense Res Dev; 1994; 4(1):19-26. PubMed ID: 7914762
[TBL] [Abstract][Full Text] [Related]
8. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
9. Antitat gene therapy: a candidate for late-stage AIDS patients.
Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
[TBL] [Abstract][Full Text] [Related]
10. A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.
Biasolo MA; Radaelli A; Del Pup L; Franchin E; De Giuli-Morghen C; Palu G
J Virol; 1996 Apr; 70(4):2154-61. PubMed ID: 8642637
[TBL] [Abstract][Full Text] [Related]
11. Intracellular expression of multimerized antisense TAR-Core RNAs inhibit the replication of human immunodeficiency virus type 1 in human CD4+ T lymphocytes.
Longchuan B; Jiangang Y; Guangwei D; Quanbi Z; Yiming S; Boqin Q
Chin Med Sci J; 1999 Mar; 14(1):13-6. PubMed ID: 12899377
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme targeting of HIV-1 LTR.
Ventura M; Wang P; Franck N; Saragosti S
Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
[TBL] [Abstract][Full Text] [Related]
13. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
Graham GJ; Maio JJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
[TBL] [Abstract][Full Text] [Related]
14. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
15. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression.
Joshi S; Van Brunschot A; Asad S; van der Elst I; Read SE; Bernstein A
J Virol; 1991 Oct; 65(10):5524-30. PubMed ID: 1895401
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
19. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
Chadwick DR; Lever AM
Gene Ther; 2000 Aug; 7(16):1362-8. PubMed ID: 10981662
[TBL] [Abstract][Full Text] [Related]
20. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
